In a 10-center study, microwave ablation offered progression free survival rates and fewer complications than surgery in the treatment of a form of thyroid cancer known as papillary thyroid carcinoma (PTC), according to research published today in Radiology, a journal of the Radiological Society of North America.
NHS introduces Pfizer’s tafamidis for ATTR-CM treatment
Tafamidis slows ATTR-CM’s progression by preventing the accumulation of protein deposits in the heart. Credit: Orawan Pattarawimonchai / Shutterstock.com The UK’s National Health Service (NHS)